Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)»Other non-follicular lymphoma (C83.8)
C83.8
Other non-follicular lymphoma
Sub-codes (10)
- C83.80 Other non-follicular lymphoma, unspecified site
- C83.81 Other non-follicular lymphoma, lymph nodes of head, face, and neck
- C83.82 Other non-follicular lymphoma, intrathoracic lymph nodes
- C83.83 Other non-follicular lymphoma, intra-abdominal lymph nodes
- C83.84 Other non-follicular lymphoma, lymph nodes of axilla and upper limb
- C83.85 Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb
- C83.86 Other non-follicular lymphoma, intrapelvic lymph nodes
- C83.87 Other non-follicular lymphoma, spleen
- C83.88 Other non-follicular lymphoma, lymph nodes of multiple sites
- C83.89 Other non-follicular lymphoma, extranodal and solid organ sites
Related indications (MeSH) (2)
Lymphoma, Primary Effusion14 drugs (11 approved, 3 experimental)
A rare neoplasm of large B-cells usually presenting as serious effusions without detectable tumor masses. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. It is associated with HUMAN HERPESVIRUS 8, most often occurring in the setting of immunodeficiency.
Lymphomatoid Granulomatosis80 drugs (54 approved, 26 experimental)
An angiocentric and angiodestructive lymphoproliferative disorder primarily involving the lungs. It is caused by an Epstein-Barr virus-induced transformation of the B-cells, in a T-cell rich environment. Clinically and pathologically it resembles EXTRANODAL NK-T-CELL LYMPHOMA.